Bright Light on Fatigue in Women Being Treated for Breast Cancer
Public ClinicalTrials.gov record NCT02658708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Bright Light on Fatigue in Women Being Treated for Breast Cancer: A Pilot Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This proposed study will examine feasibility and implement therapeutic bright light that is tailored to the individual's circadian typology to estimate its therapeutic effects on sleep/wake patterns and fatigue in breast cancer patients undergoing chemotherapy.
Study identification
- NCT ID
- NCT02658708
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 19 participants
Conditions and interventions
Interventions
- Bright blue-green light using light visor cap Other
- Dim red light using light visor cap Other
- European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire Other
- Epworth Sleepiness Scale Other
- Pittsburgh Sleep Quality Index Other
- Patient-Reported Outcomes Measurement Information System (PROMIS)-Sleep Disturbance Other
- Patient-Reported Outcomes Measurement Information System (PROMIS)-Cancer-Fatigue Other
- Digital foot candle datalogging light meter (Extech Instrument, Model SDL400) Diagnostic Test
- Polysomnography (Easy Ambulatory 2 Cadwell, Kennewick, WA) Diagnostic Test
- Horne-Ostberg Morningness-Eveningness Questionnaire Other
- Daily Fatigue and Sleep Log Other
Other · Diagnostic Test
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 11, 2015
- Primary completion
- May 8, 2017
- Completion
- May 8, 2017
- Last update posted
- Sep 24, 2017
2015 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02658708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2017 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02658708 live on ClinicalTrials.gov.